3Font J, Cervera R, Ramos-Casals M, et al. Clusters of Clinical and Features in Systemic lupus erythematosus: Analysis of 600 patients from a single center. Semin Arthritis Rheum, 2004,33: 217 -230.
4Hoohberg MC, Boyd RE , Ahearn JM, et al. Systemic lupus erythematosus : a review of Clinico-laboratory feature and immunogenetic markers in 150 patients with emphasis on demographic subets . Medicine, 1985,64:285-295.
5Voulgarelis M, Kokori SIG, Ioannidis JAP, et al. Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis, 2000, 59: 217-222.
6Keeling DM, Isonberg DA. Hematological manifestations of systemic lupus erythematosus. Blood Reviews, 1993, 7: 199- 207.
7Pistiner M ,Wallace DJ ,Nessim S,et al. Lupus erythematosus in the 1980s: a Survey of 570 patients . Semin Arthritis Rheum, 1991, 21:55-64.
8Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine, 2006, 85:147-156.
9Matsugama W, Yamamoto M, Higashimoto I, et al. TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood, 2004,104 : 184-191.
10Chen M ,Zhao M H,Zhang Y,et al. Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus. Lupus, 2004, 13:584-589.
